|
|
(127 intermediate revisions by 18 users not shown) |
Line 1: |
Line 1: |
| <table class=wikitable>
| | {{ACM}} {{SemRikken}} |
| <tr>
| |
| <td> <td>'''Mild DKA'''<td>'''Moderate DKA'''<td> '''Severe DKA''' <td>'''HHS'''
| |
| <tr>
| |
| <td>'''Plasma [[glucose]]''' <td> >250 mg/dL <td>>250 mg/dL <td>>250 mg/dL <td>>600 mg/dL
| |
| <tr>
| |
| <td>'''Arterial pH'''<td> 7.25-7.30<td> 7.00 to <7.24<td> <7.00<td> >7.30
| |
| <tr>
| |
| <td>'''Serum [[bicarbonate]] (mEq/l)'''<td> 15-18<td> 10 to <15<td> <10 <td>>18
| |
| <tr>
| |
| <td>'''Urine [[ketone]]'''<td> Positive<td> Positive<td> Positive<td> Small
| |
| <tr>
| |
| <td>'''Serum [[ketone]]'''<td> Positive<td> Positive<td> Positive<td> Small
| |
| <tr>
| |
| <td>'''Effective serum [[osmolality]]'''<td> Variable<td> Variable<td> Variable<td> >320 mOsm/kg
| |
| <tr>
| |
| <td>'''Anion gap'''<td> >10 <td> >12 <td> >12 <td> Variable
| |
| <tr>
| |
| <td>'''Mental status'''<td> Alert<td> Alert/drowsy<td> Stupor/coma<td> Stupor/coma
| |
| </table>
| |
|
| |
|
|
| |
|
| | | ''SANDBOX'' |
| {{familytree/start}}
| | [[File:Captura de Pantalla 2024-05-18 a la(s) 9.33.11 p.m..png]] |
| {{familytree | | |!| |}}
| |
| {{familytree | | A01 | A01 =<table class="v-table">
| |
| <tr class="v-firstrow"><th>123</th><th>Mild DKA</th><th>Moderate DKA</th><th>Severe DKA</th><th>HHS</th></tr>
| |
| <tr><td>Plasma glucose</td><td> >250 mg/dL</td><td>>250 mg/dL</td><td>>250 mg/dL</td><td>>600 mg/dL</td></tr>
| |
| <tr><td>Arterial pH</td><td> 7.25-7.30</td><td> 7.00 to <7.24</td><td> <7.00</td><td> >7.30</td></tr>
| |
| <tr><td>Serum bicarbonate (mEq/l)</td><td> 15-18</td><td> 10 to <15</td><td> <10</td><td>>18</td></tr>
| |
| <tr><td>Urine ketone</td><td> Positive</td><td> Positive</td><td> Positive</td><td> Small</td></tr>
| |
| <tr><td>Serum ketone</td><td> Positive</td><td> Positive</td><td> Positive</td><td> Small</td></tr>
| |
| <tr><td>Effective serum osmolality</td><td> Variable</td><td> Variable</td><td> Variable</td><td> >320 mOsm/kg</td></tr>
| |
| <tr><td>Anion gap</td><td> >10</td><td> >12</td><td> >12</td><td> Variable</td></tr>
| |
| <tr><td>Mental status</td><td> Alert</td><td> Alert/drowsy</td><td> Stupor/coma</td><td> Stupor/coma</td></tr>
| |
| </table>}}
| |
| {{familytree/end}}
| |
| | |
| | |
| ==table HIT==
| |
| | |
| {| class="wikitable"
| |
| | |
| !
| |
| | |
| ! Score = 2
| |
| | |
| ! Score = 1
| |
| | |
| ! Score = 0
| |
| | |
| |-
| |
| | |
| | '''Thrombocytopenia''' <br> Compare the highest platelet count within the sequence of declining platelet counts with the lowest count to determine the % of platelet fall. <br> (Select only 1 option)
| |
| | |
| | ♦ > 50% platelet fall AND nadir of ≥ 20 AND no surgery within preceding 3 days
| |
| | |
| | ♦ > 50% platelet fall BUT surgery within preceding 3 days OR <br> ♦ any combination of platelet fall and nadir that does not fit criteria for score 2 or score 0 (eg. 30-50% platelet fall or nadir 10-19)
| |
| | |
| | ♦ < 30% platelet fall <br> any platelet fall with nadir < 10
| |
| | |
| |-
| |
| | |
| | '''Timing (of platelet count fall or thrombosis)''' <br> Day 0 = first day of most recent heparin exposure <br> (Select only 1 option)
| |
| | |
| | ♦ platelet fall day 5-10 after start of heparin <br> ♦ platelet fall within 1 day of start of heparin AND exposure to heparin within past 5-30 days
| |
| | |
| | ♦ consistent with platelet fall days 5-10 but not clear (eg. missing counts) <br> ♦ platelet fall within 1 day of start of heparin AND exposure to heaprin in past 31-100 days <br> ♦ platelet fall after day 10
| |
| | |
| | ♦ platelet fall ≤ day 4 without exposure to heaprin in pas 100 days
| |
| | |
| |-
| |
| | |
| | '''Thrombosis (or other clinical sequelae)''' <br> (Select only 1 option)
| |
| | |
| | ♦ confirmed new thrombosis (venous or arterial) <br> skin necrosis at injection site <br> ♦ anaphylactoid reaction to IV heparin bolus <br> ♦ adrenal hemorrhage
| |
| | |
| | ♦ recurrent venous thrombosis in a patient receiving therapeutic anticoagulants <br> ♦ suspected thrombosis (awaiting confirmation with imaging) <br> ♦ erythematous skin lesions at he heparin onjection sites
| |
| | |
| | ♦ thrombosis suspected
| |
| | |
| |-
| |
| | |
| |}
| |